Mechanisms of Acquired Resistance to Tyrosine Kinase Inhibitors in Clear - Cell Renal Cell Carcinoma (ccRCC)

Publisher： Bentham Science Publishers

E-ISSN： 2212-389x|8|3|219-228

ISSN： 1574-3624

Source： Current Signal Transduction Therapy, Vol.8, Iss.3, 2013-12, pp. : 219-228

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mammalian Target of Rapamycin Inhibitors Resistance Mechanisms in Clear Cell Renal Cell Carcinoma

By  

Current Signal Transduction Therapy, Vol. 8, Iss. 3, 2013-01 ,pp. : 210-218

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanisms of Cisplatin Resistance in Clear Cell Carcinoma of the Ovary

By  

Oncology, Vol. 62, Iss. 4, 2002-07 ,pp. : 349-353

Karger

Access to resources Recommend Favorite

Challenges in the Management of EGFR-Mutated Non-Small Cell Lung Cancer Patients with Acquired Resistance to Tyrosine Kinase Inhibitors

By  

Oncology, Vol. 87, Iss. 2, 2014-07 ,pp. : 83-94

Karger

Access to resources Recommend Favorite

Evaluation of tyrosine kinase receptors in brain metastases of clear cell renal cell carcinoma reveals cMet as a negative prognostic factor

By  

HISTOPATHOLOGY, Vol. 67, Iss. 6, 2015-12 ,pp. : 799-805

John Wiley & Sons Inc

Access to resources Recommend Favorite

p21‐activated kinase 1 predicts recurrence and survival in patients with non‐metastatic clear cell renal cell carcinoma

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 5, 2015-05 ,pp. : 447-453

John Wiley & Sons Inc

Access to resources Recommend Favorite